Chemisis Labcab Iqs Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.20 M
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 102.66%
- Profit Growth 66.10%
- Ebitda 78.07%
- Net Worth 3.60%
- Total Assets 3.45%
About Chemisis Labcab Iqs
Chemisis Labcab Iqs Private Limited (CLIPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 01 May 2018 (Six years and nine months 23 days old ). Its registered office is in Nanded, Maharashtra, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Pawankumar Kabra and Sharda Kabra serve as directors at the Company.
Company Details
- Location
Nanded, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999MH2018PTC308750
- Company No.
308750
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 May 2018
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Chemisis Labcab Iqs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pawankumar Kabra  | Director | 01-May-2018 | Current |
| Sharda Kabra | Director | 01-May-2018 | Current |
Financial Performance of Chemisis Labcab Iqs.
Chemisis Labcab Iqs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 102.66% increase. The company also saw a substantial improvement in profitability, with a 66.1% increase in profit. The company's net worth moved up by a moderate rise of 3.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chemisis Labcab Iqs?
Unlock access to Chemisis Labcab Iqs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sharda Techno-Commercial Associates LlpPawankumar Kabra and Sharda Kabra are mutual person
- Makemymedicine Private Limited
Pawankumar Kabra and Sharda Kabra are mutual person
- Vilal Engineering Private Limited
Pawankumar Kabra is a mutual person
- Kabra-G Foundation
Pawankumar Kabra is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chemisis Labcab Iqs?
Unlock and access historical data on people associated with Chemisis Labcab Iqs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chemisis Labcab Iqs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemisis Labcab Iqs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
